Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Odin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|May 4, 2004
Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosisShuji Matsumura, Judy Van De Water, Patrick Leung, et al.
Digestive Diseases and Sciences|July 11, 2013
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregatesAftab Ala, David Brown, Korsa Khan, et al.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapyJames F Crismale, Valérie Martel-Laferrière, Kian Bichoupan, et al.
Journal of Autoimmunity|January 16, 2007
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosisJorge Allina, Bin Hu, Daniel M Sullivan, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2024
Clinical characteristics and HLA associations of azithromycin-induced liver injuryCaroline Conlon, Yi-Ju Li, Jawad Ahmad, et al.
Inflammatory Bowel Diseases|January 26, 2013
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasiaJoana Torres, Xiuliang Bao, Alina C Iuga, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseKian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.
World Journal of Hepatology|May 5, 2017
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infectionKian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|May 4, 2004
Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosisShuji Matsumura, Judy Van De Water, Patrick Leung, et al.
Digestive Diseases and Sciences|July 11, 2013
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregatesAftab Ala, David Brown, Korsa Khan, et al.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapyJames F Crismale, Valérie Martel-Laferrière, Kian Bichoupan, et al.
Journal of Autoimmunity|January 16, 2007
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosisJorge Allina, Bin Hu, Daniel M Sullivan, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2024
Clinical characteristics and HLA associations of azithromycin-induced liver injuryCaroline Conlon, Yi-Ju Li, Jawad Ahmad, et al.
Inflammatory Bowel Diseases|January 26, 2013
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasiaJoana Torres, Xiuliang Bao, Alina C Iuga, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseKian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.
World Journal of Hepatology|May 5, 2017
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infectionKian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Pageof 5